Mirvetuximab soravtansine has activity in platinum-sensitive epithelial ovarian cancer
Crossref DOI link: https://doi.org/10.1038/s41571-024-00888-w
Published Online: 2024-03-25
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Romero, Diana
Text and Data Mining valid from 2024-03-25
Version of Record valid from 2024-03-25
Article History
First Online: 25 March 2024